---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-25-008035"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2025-07-14T23:59:59+00:00"
generated_at: "2026-05-18T06:36:26.115010+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Zivo Bioscience raises $250k initial tranche in $2M convertible debt offering

## Summary
- Issued $250k bridge promissory note with 10% annual interest, compounded annually; due after 2 years or upon $5M+ equity financing.
- Note converts at lower of issuance price or 80% of qualified financing share price; prepayment allowed at 115% of principal.
- Accompanying warrant to purchase 1,793 shares at issuance closing price, 5-year term, immediately exercisable.
- Total offering up to $2M; proceeds for general operations; notes unsecured and junior to secured debt.

## SEC filing metadata
- accession: 0001654954-25-008035
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2025-07-14T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495425008035/0001654954-25-008035-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495425008035/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-25-008035
- JSON: https://secwatch.observer/filing/0001654954-25-008035.json
- Plain text: https://secwatch.observer/filing/0001654954-25-008035.txt

## Key facts
- Debt Financings
  Zivo Bioscience, Inc. incurred convertible notes of $250,000 with an accredited investor at 10% interest per annum maturing two years after the date of issuance.
  - Instrument: convertible notes
  - Principal: $250,000
  - Counterparty: an accredited investor
  - Rate: 10% interest per annum
  - Maturity: two years after the date of issuance
  - Event: incurrence
  source text: On July 8, 2025, Zivo Bioscience, Inc. (the“Company”) issued a Bridge Promissory Note in the principal amount of $250,000 and accompanying warrant to purchase 1,793 shares
  evidence_url: https://www.sec.gov/Archives/edgar/data/1101026/000165495425008035/0001654954-25-008035-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.